Jeffrey V. Leyton

Associate Professor at University of Ottowa, Canada

Speaker

Jeffrey Leyton is an Associate Professor at the University of Ottawa in the School of Pharmaceutical Sciences. He has extensive experience in the study and discovery of nuclear-targeted therapeutics. His research program focuses on designing novel nuclear localization signals and elucidating new nuclear transport mechanics and, applying these findings for designing nuclear-targeted therapeutics to combat cancer and inflammatory diseases. His concepts have paved the way for an improved understanding of how therapeutics can better target the nucleus and are being adapted as pharmaceuticals soon to enter human clinical trials. As a renowned expert in the field, Dr. Leyton’s research has been published in numerous scientific journals and has received recognition from the academic community and pharmaceutical industry. He is committed to advancing the field of nuclear-targeted medicines and making a meaningful impact on patient care.